SCHEMBL19637369

SCHEMBL19637369

CCOc1nc(C)c(CC)c(N(CC)CC)n1

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.35
▸ MAT2A P31153 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19637079 0.84 HTT (0.32) HTTCYP1A2
SCHEMBL21912065 0.82 KDM4E (0.34) MEN1KMT2A
SCHEMBL19637432 0.81 KDM4E (0.36) —
SCHEMBL19637255 0.80 HTT (0.34) HTT
SCHEMBL22994841 0.79 KDM4E (0.38) MEN1CYP1A2KMT2A
SCHEMBL19636917 0.74 HRH3 (0.42) —
SCHEMBL22086716 0.74 CHRNB2 (0.44) —
SCHEMBL19637446 0.72 KDM4E (0.36) MEN1KMT2A
SCHEMBL19637394 0.71 ABCB11 (0.32) CYP1A2
SCHEMBL22994768 0.70 KDM4E (0.32) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3710439-B1 KRAS G12C INHIBITORS MIRATI THERAPEUTICS INC (US) 2023-02-15 — — EP disclosed
EP-3458445-B1 KRAS G12C INHIBITORS MIRATI THERAPEUTICS INC (US) 2021-02-17 — — EP disclosed
WO-2020055760-A1 COMBINATION THERAPIES Mirati Therapeutics, Inc. (US) 2020-03-19 — — WO disclosed
WO-2017201161-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2017-11-23 — — WO disclosed
Send feedback